Publication: 713

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
      QxMD   Google Scholar   
Citation:
Ann Oncol vol 23 (1) 86-93
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
534   616  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                           
Networks:
 
Study
CALGB-9633
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: